FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045089102> ?p ?o ?g. }

• W2045089102 endingPage "2161" @default.
• W2045089102 startingPage "2150" @default.
• W2045089102 abstract "ObjectiveTo evaluate the efficacy and tolerability of a contraceptive vaginal ring and transdermal patch in the treatment of endometriosis-associated pain.DesignPatient preference cohort study.SettingAcademic center.Patient(s)Two-hundred and seven women with recurrent moderate or severe pelvic pain after conservative surgery for symptomatic endometriosis.Intervention(s)Continuous, 12-month treatment with a vaginal ring supplying 15 mcg of ethinyl E and 120 mcg of etonogestrel per day or a transdermal system delivering 20 mcg of ethinyl E and 150 mcg norelgestromin per day.Main Outcome Measure(s)Satisfaction with treatment.Result(s)One-hundred and twenty-three women preferred the ring, and 84 preferred the patch. Forty-four ring users (36%) and 51 patch users (61%) withdrew. Thirty-six of 79 subjects (46%) in the ring group and 14 of 33 (42%) in the patch group shifted from continuous to cyclic use because of irregular bleeding. Pain symptoms were reduced by both treatments, with the ring being more effective than the patch in patients with rectovaginal lesions. According to an intention-to-treat analysis, 88 of 123 ring users (72%) and 40 of 84 patch users (48%) were satisfied with the treatment received.Conclusion(s)Patients who preferred the ring were significantly more likely to be satisfied and to comply with treatment than those who chose the patch. Both systems were associated with poor bleeding control when used continuously. To evaluate the efficacy and tolerability of a contraceptive vaginal ring and transdermal patch in the treatment of endometriosis-associated pain. Patient preference cohort study. Academic center. Two-hundred and seven women with recurrent moderate or severe pelvic pain after conservative surgery for symptomatic endometriosis. Continuous, 12-month treatment with a vaginal ring supplying 15 mcg of ethinyl E and 120 mcg of etonogestrel per day or a transdermal system delivering 20 mcg of ethinyl E and 150 mcg norelgestromin per day. Satisfaction with treatment. One-hundred and twenty-three women preferred the ring, and 84 preferred the patch. Forty-four ring users (36%) and 51 patch users (61%) withdrew. Thirty-six of 79 subjects (46%) in the ring group and 14 of 33 (42%) in the patch group shifted from continuous to cyclic use because of irregular bleeding. Pain symptoms were reduced by both treatments, with the ring being more effective than the patch in patients with rectovaginal lesions. According to an intention-to-treat analysis, 88 of 123 ring users (72%) and 40 of 84 patch users (48%) were satisfied with the treatment received. Patients who preferred the ring were significantly more likely to be satisfied and to comply with treatment than those who chose the patch. Both systems were associated with poor bleeding control when used continuously." @default.
• W2045089102 created "2016-06-24" @default.
• W2045089102 creator A5013743669 @default.
• W2045089102 creator A5014325812 @default.
• W2045089102 creator A5035059688 @default.
• W2045089102 creator A5060819005 @default.
• W2045089102 creator A5069350522 @default.
• W2045089102 creator A5087414064 @default.
• W2045089102 date "2010-05-01" @default.
• W2045089102 modified "2023-10-16" @default.
• W2045089102 title "Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis" @default.
• W2045089102 cites W1876522572 @default.
• W2045089102 cites W1972232813 @default.
• W2045089102 cites W1972249329 @default.
• W2045089102 cites W1980537630 @default.
• W2045089102 cites W1993049605 @default.
• W2045089102 cites W1994163427 @default.
• W2045089102 cites W1996394976 @default.
• W2045089102 cites W1999804326 @default.
• W2045089102 cites W2008918969 @default.
• W2045089102 cites W2011294879 @default.
• W2045089102 cites W2015023548 @default.
• W2045089102 cites W2021078647 @default.
• W2045089102 cites W2027541335 @default.
• W2045089102 cites W2031232537 @default.
• W2045089102 cites W2050143859 @default.
• W2045089102 cites W2054400702 @default.
• W2045089102 cites W2062896185 @default.
• W2045089102 cites W2068661759 @default.
• W2045089102 cites W2071000286 @default.
• W2045089102 cites W2086933112 @default.
• W2045089102 cites W2095924616 @default.
• W2045089102 cites W2097550528 @default.
• W2045089102 cites W2099018240 @default.
• W2045089102 cites W2101375111 @default.
• W2045089102 cites W2105609213 @default.
• W2045089102 cites W2117122876 @default.
• W2045089102 cites W2126207591 @default.
• W2045089102 cites W2127971155 @default.
• W2045089102 cites W2151301625 @default.
• W2045089102 cites W2166974601 @default.
• W2045089102 cites W2167806966 @default.
• W2045089102 cites W2170519509 @default.
• W2045089102 cites W2319983832 @default.
• W2045089102 cites W2401134385 @default.
• W2045089102 cites W2477008945 @default.
• W2045089102 cites W2616141209 @default.
• W2045089102 cites W3022423927 @default.
• W2045089102 doi "https://doi.org/10.1016/j.fertnstert.2009.01.071" @default.
• W2045089102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19328469" @default.
• W2045089102 hasPublicationYear "2010" @default.
• W2045089102 type Work @default.
• W2045089102 sameAs 2045089102 @default.
• W2045089102 citedByCount "87" @default.
• W2045089102 countsByYear W20450891022012 @default.
• W2045089102 countsByYear W20450891022013 @default.
• W2045089102 countsByYear W20450891022014 @default.
• W2045089102 countsByYear W20450891022015 @default.
• W2045089102 countsByYear W20450891022016 @default.
• W2045089102 countsByYear W20450891022017 @default.
• W2045089102 countsByYear W20450891022018 @default.
• W2045089102 countsByYear W20450891022019 @default.
• W2045089102 countsByYear W20450891022020 @default.
• W2045089102 countsByYear W20450891022021 @default.
• W2045089102 countsByYear W20450891022022 @default.
• W2045089102 countsByYear W20450891022023 @default.
• W2045089102 crossrefType "journal-article" @default.
• W2045089102 hasAuthorship W2045089102A5013743669 @default.
• W2045089102 hasAuthorship W2045089102A5014325812 @default.
• W2045089102 hasAuthorship W2045089102A5035059688 @default.
• W2045089102 hasAuthorship W2045089102A5060819005 @default.
• W2045089102 hasAuthorship W2045089102A5069350522 @default.
• W2045089102 hasAuthorship W2045089102A5087414064 @default.
• W2045089102 hasBestOaLocation W20450891021 @default.
• W2045089102 hasConcept C126322002 @default.
• W2045089102 hasConcept C141071460 @default.
• W2045089102 hasConcept C197934379 @default.
• W2045089102 hasConcept C205679159 @default.
• W2045089102 hasConcept C2775842315 @default.
• W2045089102 hasConcept C2775944032 @default.
• W2045089102 hasConcept C2778375690 @default.
• W2045089102 hasConcept C2779076696 @default.
• W2045089102 hasConcept C2779522080 @default.
• W2045089102 hasConcept C2779755712 @default.
• W2045089102 hasConcept C2780136519 @default.
• W2045089102 hasConcept C2781197234 @default.
• W2045089102 hasConcept C2908647359 @default.
• W2045089102 hasConcept C29456083 @default.
• W2045089102 hasConcept C2986817661 @default.
• W2045089102 hasConcept C71924100 @default.
• W2045089102 hasConcept C98274493 @default.
• W2045089102 hasConcept C99454951 @default.
• W2045089102 hasConceptScore W2045089102C126322002 @default.
• W2045089102 hasConceptScore W2045089102C141071460 @default.
• W2045089102 hasConceptScore W2045089102C197934379 @default.
• W2045089102 hasConceptScore W2045089102C205679159 @default.
• W2045089102 hasConceptScore W2045089102C2775842315 @default.
• W2045089102 hasConceptScore W2045089102C2775944032 @default.

• next